Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Experts question continuation of Covishield vaccine trials in India despite adverse event report
Censure SII’s move to file a defamation suit on the participant who reported the adverse event, stating that it will discourage…
Moderna announces vaccine efficacy of 94.1 per cent, to file for EUA with US FDA
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of…
Eisai and Wren Therapeutics to collaborate for drug discovery for synucleinopathies
This collaboration aims to develop a disease-modifying treatment for synucleinopathies based on network kinetics of α-synuclein…
UK to procure additional two million doses of mRNA vaccine against COVID-19
UK government has now secured seven million doses of mRNA-1273
Gilead Sciences, AIDS Society of India survey highlights disruption in HIV care during COVID-19
Main reasons for disruption in India include travel constraints, fear of getting COVID-19
China has highest PD-1/PD-L1 combination immuno-oncology therapies clinical trials growth:…
Between 2017 and 2019, the number of clinical trials initiated for PD-1/PD-L1 targeted combination therapies increased…
Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma
It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including…
Unichem gets US FDA approval for Atenolol and Chlorthalidone Tablets
They are indicated for the treatment of hypertension, to lower blood pressure
Dr Reddy’s to acquire select anti-allergy brands from Glenmark in Russia and other CIS countries
The acquired brands represent two types of products, mometasone mono product and combination of mometasone with azelastine.